CD68-positive tumor-associated macrophages predict unfavorable treatment outcomes in classical Hodgkin lymphoma in correlation with interim fluorodeoxyglucose-positron emission tomography assessment-Reference-Cited by-同舟云学术

CD68-positive tumor-associated macrophages predict unfavorable treatment outcomes in classical Hodgkin lymphoma in correlation with interim fluorodeoxyglucose-positron emission tomography assessment

Published:2014-06-27 Issue:2 Volume:56 Page:332-341
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Touati Mohamed,Delage-Corre Manuela,Monteil Jacques,Abraham Julie,Moreau Stéphane,Remenieras Liliane,Gourin Marie-Pierre,Dmytruk Nataliya,Olivrie Agnès,Turlure Pascal,Girault Stéphane,Labrousse François,Preux Pierre-Marie,Jaccard Arnaud,Bordessoule Dominique

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.917636

Reference45 articles.

1. Hodgkin lymphoma: 2012 update on diagnosis, risk-stratification, and management

2. Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973-2009

3. A Prognostic Score for Advanced Hodgkin's Disease

4. Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

5. Macrophages predict treatment outcome in Hodgkin's lymphoma

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Empowering macrophages: the cancer fighters within the tumour microenvironment in mantle cell lymphoma;Frontiers in Immunology;2024-03-19

2. Unraveling the Immune Microenvironment in Classic Hodgkin Lymphoma: Prognostic and Therapeutic Implications;Biology;2023-06-15

3. The Tumor Microenvironment in Classic Hodgkin’s Lymphoma in Responder and No-Responder Patients to First Line ABVD Therapy;Cancers;2023-05-17

4. Classic Hodgkin lymphoma with marked granulomatous reaction: A clinicopathologic study of 20 cases;Human Pathology;2023-04

5. Histological Subtypes Drive Distinct Prognostic Immune Signatures in Classical Hodgkin Lymphoma;Cancers;2022-10-06